[Federal Register Volume 85, Number 22 (Monday, February 3, 2020)]
[Notices]
[Pages 5984-5985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01959]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-576]


Bulk Manufacturer of Controlled Substances Application: Noramco 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before April 3, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701

[[Page 5985]]

Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on July 17, 2019, Noramco Inc., 1550 Olympic Drive, 
Athens, Georgia 30601 applied to be registered as a bulk manufacturer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Cathinone...............................            1235               I
Gamma Hydroxybutyric Acid...............            2010               I
Marihuana Extract.......................            7350               I
Marihuana...............................            7360               I
Tetrahydrocannabinols...................            7370               I
Codeine-N-oxide.........................            9053               I
Dihydromorphine.........................            9145               I
Hydromorphinol..........................            9301               I
Morphine-N-oxide........................            9307               I
Normorphine.............................            9313               I
Amphetamine.............................            1100              II
Lisdexamfetamine........................            1205              II
Methylphenidate.........................            1724              II
Nabilone................................            7379              II
Codeine.................................            9050              II
Dihydrocodeine..........................            9120              II
Oxycodone...............................            9143              II
Hydromorphone...........................            9150              II
Hydrocodone.............................            9193              II
Levorphanol.............................            9220              II
Morphine................................            9300              II
Oripavine...............................            9330              II
Thebaine................................            9333              II
Oxymorphone.............................            9652              II
Noroxymorphone..........................            9668              II
Alfentanil..............................            9737              II
Sufentanil..............................            9740              II
Carfentanil.............................            9743              II
Tapentadol..............................            9780              II
Fentanyl................................            9801              II
------------------------------------------------------------------------

    The company plans to manufacture bulk active pharmaceutical 
ingredients (APIs) and reference standards for distribution to their 
customers.
    In reference to drug codes 7350 (marihuana extract), 7360 
(marihuana), and 7370 (tetrahydrocannabinols), the company plans to 
bulk manufacture these drugs as synthetics. No other activities for 
these drugs are authorized for this registration.

    Dated: January 24, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-01959 Filed 1-31-20; 8:45 am]
 BILLING CODE 4410-09-P